By Ayako Wakatsuki Pedersen, Ph.D., Senior Vice President of Translational Research at IO Biotech | Making the tumor microenvironment hostile to cancer cells and immune-suppressive cells may transform ...

More U.S. investors are launching companies stateside that license technology from China, even as Congress moves to crack down on some Chinese companies through the BIOSECURE Act. Read more.

These data, as well as new pre-clinical data from IO Biotech’s second vaccine candidate, IO112, will be presented at the Society for Immunotherapy of Cancer’s 39th Annual Meeting in Houston on ...

STAT gathered reactions from leaders across biotech and pharma about what the new Trump era could mean for them.

Previous reports have disclosed the development of Shigella conjugate vaccines (SCVs) using a platform squaric acid chemistry conjugation approach and carrier protein recombinant fragment of tetanus ...

Michael Dunlop believes that events such as the NW200 and Isle of Man TT will "thrive regardless" despite his assertion that national road racing is "finished". The Ballymoney man broke his uncle ...

On Aug. 22, the Food and Drug Administration approved and authorized newer formulations of the two mRNA vaccines, from Pfizer/BioNTech and Moderna, for ages 6 months and up. About a week later ...

Tetanus leads to death in about 1 in 10 cases. Several vaccines are used to prevent tetanus among children, adolescents, and adults including DTaP, Tdap, DT, and Td. Tetanus toxoid (contained in Tdap, ...

The poster presentation will provide an update on ATI-1701, Appili's potential first-in-class vaccine candidate for the prevention of tularemia caused by F. tularensis and will summarize the latest ...

On any list of the world’s most translated books, you are likely to find the Bible, “The Communist Manifesto” — and a collection of stories featuring witches, talking animals, goose girls ...